Skip to Content

Dorzolamide Ophthalmic Solution

Last Updated: November 28, 2017
Status: Current

Dorzolamide Ophthalmic Solution

Products Affected - Description
  • Trusopt ophthalmic solution, Merck
    2%, 10 mL Ocumeter Plus bottle, 1 count (NDC 00006-3519-36)

 
Dorzolamide ophthalmic solution, Akorn
2%, 10 mL bottle, 1 count (NDC 50383-0232-10)
 
Dorzolamide ophthalmic solution, Sandoz
2%, 10 mL bottle, 1 count (NDC 61314-0019-10)
 
Dorzolamide ophthalmic solution, Teva
2%, 10 mL bottle, 1 count (NDC 00591-2481-79)
2%, 10 mL bottle, 1 count (NDC 00093-7618-43)
 
Dorzolamide ophthalmic solution, Valeant
2%, 10 mL bottle, 1 count (NDC 24208-0485-10)
Reason for the Shortage
    • Akorn has dorzolamide ophthalmic solution on shortage due to manufacturing delays.
    • Merck did not provide a reason for the shortage.
    • Sandoz did not provide a reason for the shortage.
    • Teva did not provide a reason for the shortage.
    • Valeant has dorzolamide ophthalmic solution on shortage due to manufacturing delays.
Available Products
  • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Akorn has dorzolamide 2% ophthalmic solution on allocation.
    • Merck has Trusopt 2% ophthalmic solution on back order and the company cannot estimate a release date.
    • Sandoz has dorzolamide 2% ophthalmic solution on back order and the company cannot estimate a release date.
    • Teva has dorzolamide 2% ophthalmic solution on back order and the company cannot estimate a release date.
    • Valeant has dorzolamide 2% ophthalmic solution on back order and the company estimates a release date of early-January 2018.

Updated

November 28, October 30, 2017, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide